Sonoma PharmaceuticalsSNOA 
$3.11-1.68%24h
-1.68%24h
Global rank26122
Market cap$10.55M
Change 7d-4.40%
YTD Performance1626.11%
SP500 benchmarkOutperform
P/E-2.04
P/S0.79
Revenue$13.27M
Earnings-$5.15M
Dividend yield-
Sonoma Pharmaceuticals SNOA Total Debt
SNOA Total Debt in 2022: $162.00K
According to Sonoma Pharmaceuticals latest financial reports the total debt is $162.00K, an decrease of -47.57% to 2022. At the end of 2022 company had $309.00K total debt. This figure represents the debts and financial obligations that Sonoma Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Sonoma Pharmaceuticals SNOA Total Debt History from 2023 to 2022
-
Value:-
SNOA Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $162.00K | -47.57% |
| 2022 | $309.00K | -83.20% |
| 2021 | $1.84M | 682.55% |
| 2020 | $235.00K | 1858.33% |
| 2019 | $12.00K | - |
View the Top Total Debt Stocks 
